New generic shot for schizophrenia put to the test
NCT ID NCT07547384
First seen Apr 25, 2026 · Last updated May 14, 2026 · Updated 7 times
Summary
This study compares a generic version of aripiprazole injection (400 mg) to the brand-name drug Abilify Maintena® in people with stable schizophrenia. About 116 participants will receive five shots of each drug, one month apart, to see if the generic works the same in the body. The goal is to confirm the generic is a safe and effective alternative for long-term symptom control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.